ARKG

ARK Genomic Revolution ETFARK$29.59-0.41 (-1.35%)

AUM $1.04BER 0.75%NAV $29.76Holdings 50Inception Oct 2014

Price Chart

Key Statistics

Previous Close

$29.91

Day Range

$29.54$29.59

52-Week Range

$20.34$34.24

Avg Volume

2.3M

Dividend Yield

—

Expense Ratio

0.75%

AUM

$1.04B

Shares Outstanding

35.0M

ETF Grades

?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.

Sector Breakdown

Sector	Weight %
Healthcare	100.00%

Country Allocation

Country	Weight %
United States	84.23%
Switzerland	8.46%
Other	3.60%
United Kingdom	2.61%
Germany	1.10%

Fund Information

Issuer: ARK
Category: Healthcare
Types: Innovation Biotech Active Genomics Growth Long-Term Bond
Inception Date: Oct 30, 2014
Exchange: BATS
Description: ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.

Similar ETFs

Symbol	Name	AUM	Expense Ratio	Holdings
IWM	iShares Russell 2000 ETF	$75.96B	0.19%	1,931
XLV	State Street Health Care Select Sector SPDR ETF	$38.76B	0.08%	59
VHT	Vanguard Health Care ETF	$18.60B	0.09%	411
VTWO	Vanguard Russell 2000 ETF	$14.50B	0.06%	1,969
IWO	iShares Russell 2000 Growth ETF	$13.72B	0.24%	1,096

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund issued by ARK that launched on Oct 30, 2014. It currently manages $1.04B in assets under management. The fund charges an expense ratio of 0.75%. The fund holds 50 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 58.5% of the fund

Rank	Symbol	Name	Weight %	Shares	Market Value
1	CRSP	CRISPR THERAPEUTICS AG	9.50%	1,984,206	$109.5M
2	TWST	TWIST BIOSCIENCE CORP	9.43%	1,847,454	$108.7M
3	TEM	TEMPUS AI INC-CL A	8.80%	1,971,605	$101.4M
4	TXG	10X GENOMICS INC-CLASS A	5.64%	3,037,141	$65.1M
5	BEAM	BEAM THERAPEUTICS INC	5.46%	2,086,497	$62.9M
6	ILMN	ILLUMINA INC	4.02%	369,085	$46.3M
7	NTRA	NATERA INC	4.00%	229,018	$46.1M
8	NTLA	INTELLIA THERAPEUTICS INC	3.93%	2,855,231	$45.3M
9	PSNL	PERSONALIS INC	3.85%	7,532,542	$44.4M
10	ABSI	ABSCI CORP	3.84%	11,158,202	$44.3M
11	RXRX	RECURSION PHARMACEUTICALS-A	3.58%	11,790,540	$41.3M
12	GH	GUARDANT HEALTH INC	3.55%	466,050	$41.0M
13	CDNA	CAREDX INC	3.29%	1,888,257	$37.9M
14	VCYT	VERACYTE INC	2.70%	939,525	$31.1M
15	CMPS	COMPASS PATHWAYS PLC	2.47%	3,115,626	$28.5M

Detailed Returns

Period	ETF	Cat. Avg
1D	-1.35%	—
1W	-5.28%	—
1M	+19.22%	—
3M	-6.00%	—
6M	-0.67%	—
YTD	+1.41%	—
1Y	+32.39%	—
3Y	+4.71%	—
5Y	-66.99%	—

Moving Averages

20-Day MA

$28.57

Above 20-Day MA

50-Day MA

$28.24

Above 50-Day MA

200-Day MA

$28.30

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$34.24

Current Price

$29.59

52-Week Low

$20.34

$20.34$34.24

Current Yield

—

Annual Dividend

$2.4964

Frequency

1x/year

Last Ex-Date

Dec 29, 2021

Dividend History

Ex-Date	Amount	Pay Date
Dec 29, 2021	$0.3824	Dec 31, 2021
Dec 29, 2020	$0.7901	Dec 31, 2020
Dec 27, 2019	$1.0539	Dec 31, 2019
Dec 27, 2018	$0.2700	Dec 31, 2018
Dec 27, 2018	$0.1963	Dec 31, 2018
Dec 27, 2017	$0.1927	Dec 29, 2017
Dec 27, 2017	$0.1350	Dec 29, 2017

Dividend Payments Over Time

Category Comparison

Metric	ARKG	Healthcare(212 ETFs)	Innovation(5 ETFs)
Fund Info
Expense Ratio	0.75%	0.61%	0.75%
AUM	$1.04B	$1.20B	$2.23B
Dividend Yield	—	3.25%	0.72%
Avg Volume	2.3M	342.6K	2.4M
Holdings	50	181	37
Performance
1-Month Return	+12.83%	+6.30%	+13.68%
6-Month Return	-4.68%	+6.13%	-10.17%
YTD Return	+3.24%	+2.71%	-0.18%
1-Year Return	+33.23%	+28.23%	+46.67%

Compare with Another ETF

Search for an ETF to compare with ARKG:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.